Can the Monocyte/HDL Ratio be used as A Marker to Predict Fatty Liver and Its Stages?
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 3
Abstract
Background: Our study aims to determine whether the monocyte/HDL ratio is a marker that can be used to predict the presence and stage of non-alcoholic fatty liver. Material and Method: Patients aged 18-65 years without known chronic diseases and medication use who applied to our hospital for a check-up were included in the study. Patients were divided into 4 groups based on ultrasonography findings: those without hepatosteatosis, those with stage 1, stage 2, and stage 3 hepatosteatosis. Groups were compared in terms of fasting glucose, insulin resistance, lipid profile, liver function tests, monocyte/HDL ratios. Results: Fasting glucose, insulin resistance, total cholesterol, LDL cholesterol, triglycerides, alanine aminotransferase, monocytes, and monocyte/HDL ratio were significantly higher in the group with hepatosteatosis than in the group without hepatosteatosis, and this increase was directly proportional to the stage. HDL was significantly lower in the hepatosteatosis group than in the group without hepatosteatosis, and HDL decreased further as the stage of hepatosteatosis increased. No difference was found between the groups in terms of aspartate aminotransferase. Multivariate regression analyses revealed that hepatosteatosis was independently associated with alanine aminotransferase, insulin resistance, and monocyte/HDL ratio. Conclusion: Monocyte/HDL ratio can be considered a simple, easily accessible, and inexpensive marker to predict the presence and stages of hepatosteatosis.
Authors and Affiliations
Ece Yiğit, İlknur Sayar
Keywords
Related Articles
- EP ID EP719135
- DOI https://doi.org/10.5281/zenodo.8134906
- Views 66
- Downloads 0
Diagnosis and Treatment of Monogenic Hypertension in Children
Hypertension (HT) is a common public health problem that develops due to primary and secondary causes. The prevalence of HT in children and adolescents is 3.6%. In childhood HT, complex and polygenic factors such as gene...
Is Obesity an Obstacle to Being A kidney Donor? Experiences from A High-Volume Center
Background: Donor obesity is considered a relative contraindication to kidney donation by most transplant centers because of concerns about short-term and long-term morbidity and mortality. In this study, the impact of k...
The Relationship Between the HALP Score and Gastric Cancer Prognosis
Background: Gastric adenocarcinoma is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. As most patients are diagnosed in the advanced stage of the disease, the prognosis is...
The Effect of Hot Pepper, Sumac, and Chewing on Gastric inhibitory peptide, Glucagon-like Peptide, and Cholecystokinin Hormone Secretion
Background: The influence of various dietary factors on metabolic responses and gastrointestinal function has been the subject of extensive research. In this study, we aimed to investigate the effects of capsaicin, chewi...
Dyslipidemia and Kidney: An Updated View
Dyslipidemia is a common concern in various kidney-related conditions, including chronic kidney disease, nephrotic syndrome, kidney transplant patients, and those undergoing dialysis. Dyslipidemia is a significant risk f...